Cargando…

Dosing vitamin C in critically ill patients with special attention to renal replacement therapy: a narrative review

RATIONALE/METHODS: The primary aim of the present contribution is to find a literature-based agreement on dose adjustments of vitamin C in critically ill patients undergoing renal replacement therapy (RRT). AVAILABLE DATA/STUDY RESULTS: Critical illness is frequently accompanied by severe vitamin C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Honore, Patrick M., Spapen, Herbert D., Marik, Paul, Boer, Willem, Oudemans-van Straaten, Heleen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016079/ https://www.ncbi.nlm.nih.gov/pubmed/32052229 http://dx.doi.org/10.1186/s13613-020-0640-6

Ejemplares similares

Response to the letter of Morán et al. regarding our use of an inaccurate reference for the maximal dose of vitamin C in G6PD deficiency
por: Honore, Patrick M., et al.
Publicado: (2020)

Vitamin therapy in critically ill patients: focus on thiamine, vitamin C, and vitamin D
por: Amrein, Karin, et al.
Publicado: (2018)

Cefepime-induced neurotoxicity in critically ill patients undergoing continuous renal replacement therapy: beware of dose reduction!
por: Honore, Patrick M., et al.
Publicado: (2015)

Commentary to “Dosing vitamin C in critically ill patients with special attention to renal replacement therapy: a narrative review”
por: Morán, J. M., et al.
Publicado: (2020)

Dosing adjuvant vitamin C in critically ill patients undergoing continuous renal replacement therapy: We are not there yet!
por: Honore, Patrick M., et al.
Publicado: (2019)

Glutamine supplementation in the critically ill: friend or foe?
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2014)

Citrate for continuous renal replacement therapy: safer, better and cheaper
por: Oudemans-van Straaten, Heleen M
Publicado: (2014)

Adjuvant Vitamin C in critically ill patients undergoing renal replacement therapy: What’s the right dose?
por: Marik, Paul E, et al.
Publicado: (2018)

Citrate dose for continuous hemofiltration: effect on calcium and magnesium balance, parathormone and vitamin D status, a randomized controlled trial
por: Boer, Willem, et al.
Publicado: (2021)

Clinical review: Patency of the circuit in continuous renal replacement therapy
por: Joannidis, Michael, et al.
Publicado: (2007)

Response to “Adjuvant vitamin C in cardiac arrest patients undergoing renal replacement therapy: an appeal for a higher high-dose”
por: Spoelstra – de Man, Angelique M. E., et al.
Publicado: (2018)

Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2012)

Biomarker validity in the critically ill: all must face the (continuous) renal replacement challenge!
por: Honore, Patrick M., et al.
Publicado: (2015)

Vitamin C Dosing During Continuous Renal Replacement Therapy: The Last Word is Not Said!
por: Honore, Patrick M., et al.
Publicado: (2019)

Making sense of early high-dose intravenous vitamin C in ischemia/reperfusion injury
por: Spoelstra-de Man, Angelique M. E., et al.
Publicado: (2018)

Clinical review: Anticoagulation for continuous renal replacement therapy - heparin or citrate?
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2011)

Normal saline as resuscitation fluid in critically ill patients: not dead yet!
por: Honore, Patrick M., et al.
Publicado: (2016)

Biomarkers in critical illness: have we made progress?
por: Honore, Patrick M, et al.
Publicado: (2016)

Adjuvant vitamin C in cardiac arrest patients undergoing renal replacement therapy: an appeal for a higher high-dose
por: Honore, Patrick M., et al.
Publicado: (2018)

Modification of Nutrition Therapy During Continuous Renal Replacement Therapy in Critically Ill Pediatric Patients: A Narrative Review and Recommendations
por: Jonckheer, Joop, et al.
Publicado: (2018)

Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies?
por: Honore, Patrick M., et al.
Publicado: (2018)

Rapid screening of critically ill patients for low plasma vitamin C concentrations using a point-of-care oxidation–reduction potential measurement
por: Rozemeijer, Sander, et al.
Publicado: (2021)

Colistin dosing for treatment of multidrug-resistant Pseudomonas in critically ill patients - please, be adequate!
por: Honoré, Patrick M, et al.
Publicado: (2014)

Albumin rather than C-reactive protein may be valuable in predicting and monitoring the severity and course of acute respiratory distress syndrome in critically ill patients with or at risk for the syndrome after new onset fever
por: Hoeboer, Sandra H, et al.
Publicado: (2015)

The blind spot in high-dose tigecycline pharmacokinetics in critically ill patients: membrane adsorption during continuous extracorporeal treatment
por: Honore, Patrick M, et al.
Publicado: (2015)

Vitamin C revisited
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2014)

Estimating Vitamin C Status in Critically Ill Patients with a Novel Point-of-Care Oxidation-Reduction Potential Measurement
por: Rozemeijer, Sander, et al.
Publicado: (2019)

Renal and neurological side effects of colistin in critically ill patients
por: Spapen, Herbert, et al.
Publicado: (2011)

Hemoadsorption therapy in the critically ill: solid base but clinical haze
por: Honoré, Patrick M., et al.
Publicado: (2019)

New generation indirect calorimeters for measuring energy expenditure in the critically ill: a rampant or reticent revolution?
por: De Waele, Elisabeth, et al.
Publicado: (2016)

Early high protein intake is associated with low mortality and energy overfeeding with high mortality in non-septic mechanically ventilated critically ill patients
por: Weijs, Peter JM, et al.
Publicado: (2014)

Adjuvant vitamin C for sepsis: mono or triple?
por: Spoelstra–de Man, Angelique M. E., et al.
Publicado: (2019)

Dialysis dose in acute kidney injury: no time for therapeutic nihilism – a critical appraisal of the Acute Renal Failure Trial Network study
por: Ronco, Claudio, et al.
Publicado: (2008)

Vitamin C: should we supplement?
por: Spoelstra-de Man, Angélique M.E., et al.
Publicado: (2018)

Circulating pro-apoptotic mediators in burn septic acute renal failure
por: Oudemans-van Straaten, Heleen M
Publicado: (2008)

Renal failure in critically ill patients, beware of applying (central venous) pressure on the kidney
por: Chen, Xiukai, et al.
Publicado: (2018)

Neutrophil gelatinase-associated lipocalin elimination by renal replacement therapy: minding the membrane!
por: Honore, Patrick M., et al.
Publicado: (2016)

What a Clinician Should Know About a Renal Replacement Membrane?
por: Honore, Patrick M., et al.
Publicado: (2018)

Eliminating endotoxin by polymyxin B hemoperfusion and/or continuous renal replacement therapy: should the focus be on timing, dosing, and type of renal epuration?
por: Honore, Patrick M., et al.
Publicado: (2019)

Low skeletal muscle area is a risk factor for mortality in mechanically ventilated critically ill patients
por: Weijs, Peter JM, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hf47r2pt08dtlseop6ivrpkr8k